|
|
News Breaks | | | | October 15, 2012 | | 09:15 EDT |  | BSX | Boston Scientific November volatility bid up into Q3
Boston Scientific October and November call option implied volatility is at 48, February is at 29; compared to its 26-week average of 35 according to Track Data, suggesting larger near term price movement into the expected release of Q3 results on October 18. | |
|
News For BSX From The Last 14 Days Check below for free stories on BSX the last two weeks. |
|
|
| June 18, 2013 | | 05:23 EDT |  | BSX | Boston Scientific Vercise DBS System demonstrates improvement in motor function
Patients with Parkinson's disease using the Boston Scientific Vercise DBS, or deep brain stimulation, System showed a significant improvement in motor scores according to interim data from the VANTAGE DBS study. The Vercise DBS System incorporates multiple independent current control, which is designed to selectively stimulate targeted areas in the brain, providing physicians with fine control of stimulation. Preliminary analysis of the VANTAGE study displays approximately 60% mean improvement in motor function at six months post implant, as assessed by UPDRS III when compared to baseline. | | | June 17, 2013 | | 17:04 EDT | | BSX | Boston Scientific begins patient enrollment in U.S. clinical trial for Vercise
 Subscribe for More Information | |
|
|
|
|
|
|
